Streetbeat News

Assets

INDP

Indaptus Therapeutics reported a FY EPS of $(1.83), surpassing the $(1.95) estimate. Despite a 5.78% increase in losses from the previous year, its $13.4M cash balance is expected to sustain operations through Q3 of 2024.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:39 am

ARCO

Arcos Dorados announced plans to open 80 to 90 new restaurants in 2024, with approximately 90% being free-standing units. The company anticipates total capital expenditures for 2024 to be between $300M and $350M.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:36 am

TRDA

Entrada Therapeutics announced its cash balance of $352M, extending its cash runway through Q2 2026. This financial stability is crucial for its ongoing and future projects.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:22 am

NVDA

ORCL

U.S. markets closed higher with the S&P 500 hitting a record high, driven by Oracle's rally and positive consumer price data. Oracle announced a collaboration with Nvidia, boosting their shares. Asian markets saw mixed results, while European markets and commodities, especially crude oil, traded higher. Economic data showed a rise in inflation to 3.2% year-over-year in February 2024.

Portfolio Pulse from Akanksha Bakshi

March 13, 2024 | 11:22 am

FCX

SCCO

Shares of copper companies, including FCX and SCCO, are trading higher due to a rise in copper prices following an agreement by Chinese smelters to reduce production.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:14 am

PRQR

ProQR Therapeutics announced that its 2023 cash and cash equivalents totaling €118.9 million are expected to fund operations into mid-2026. This financial stability is crucial for the company's ongoing research and development activities.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:10 am

ADCT

ADC Therapeutics announced that its 2023 cash and cash equivalents totaling $278.6 million are expected to provide the company with a cash runway into the fourth quarter of 2025. This financial stability is crucial for the company's operations and future projects.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:04 am

FLOKIUSD

Cryptocurrency analyst Rekt Capital suggests FLOKI could reach new highs if it successfully retests two critical resistance levels at $0.000021 and $0.0000625, transforming them into support levels. This analysis comes amid FLOKI's recent token burns, reducing its circulating supply, and a spike in social dominance. Another analyst, Inmortal, also expressed optimism for FLOKI's potential rise, comparing it to the recent surge in PEPE. Currently, FLOKI is trading up 6.46% at $0.0002771.

Portfolio Pulse from Mehab Qureshi

March 13, 2024 | 11:00 am

VGK

Eurozone's industrial production for January experienced a significant decline of 3.2%, which was worse than the estimated 1.8% decrease. This follows a revised prior increase of 1.6%.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 10:00 am

EWJ

Japan's Space One Kairos rocket exploded shortly after its launch, marking a significant setback for the country's space exploration efforts. The incident could have implications for companies and ETFs involved in the space industry or with exposure to Japanese markets.

Portfolio Pulse from Charles Gross

March 13, 2024 | 9:50 am